In a report released today, Yanan Zhu from Wells Fargo maintained a Buy rating on Arcturus Therapeutics (ARCT – Research Report), with a price target of $50.00. The company’s shares closed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback